SEC 13F Intelligence

Westhampton Capital, LLC / ABBV

Westhampton Capital, LLC’s Abbvie Inc Position

Does Westhampton Capital, LLC own Abbvie Inc (ABBV)? Yes9.8K shares worth $2M (+1.00% of its 13F portfolio) as of Q1 2026.

Position Value
$2M
Q1 2026
Shares
9.8K
% of Portfolio
+1.00%
Quarters Held
28
currently held

Position History ABBV

Reported value by quarter
Q2 ’19: $276,000Q2 ’19Q3 ’19: $235,000Q4 ’19: $274,000Q1 ’20: $325,000Q2 ’20: $484,000Q2 ’20Q3 ’20: $521,000Q4 ’20: $660,000Q1 ’21: $1MQ2 ’21: $1MQ2 ’21Q3 ’21: $1MQ4 ’21: $1MQ1 ’22: $2MQ2 ’22: $2MQ2 ’22Q3 ’22: $1MQ4 ’22: $2MQ1 ’23: $2MQ2 ’23: $1MQ2 ’23Q3 ’23: $2MQ4 ’23: $1MQ1 ’24: $1MQ2 ’24: $2MQ2 ’24Q3 ’24: $2MQ4 ’24: $2MQ1 ’25: $2MQ2 ’25: $2MQ2 ’25Q3 ’25: $2MQ4 ’25: $2MQ1 ’26: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.8K$2M+1.00%
Q4 20259.8K$2M+1.06%
Q3 20259.9K$2M+1.12%
Q2 202510.0K$2M+0.96%
Q1 202510.2K$2M+1.16%
Q4 202410.2K$2M+0.92%
Q3 20248.8K$2M+0.88%
Q2 20248.8K$2M+0.82%
Q1 20247.8K$1M+0.78%
Q4 20238.6K$1M+0.79%
Q3 202310.3K$2M+0.99%
Q2 202310.4K$1M+0.91%
Q1 202310.4K$2M+1.07%
Q4 202210.4K$2M+1.14%
Q3 202210.3K$1M+1.04%
Q2 202210.1K$2M+1.09%
Q1 202210.0K$2M+1.05%
Q4 202110.0K$1M+0.83%
Q3 202110.9K$1M+0.80%
Q2 202110.6K$1M+0.78%
Q1 202110.1K$1M+0.76%
Q4 20206.2K$660,000+0.49%
Q3 20205.9K$521,000+0.43%
Q2 20204.9K$484,000+0.42%
Q1 20204.3K$325,000+0.34%
Q4 20193.1K$274,000+0.22%
Q3 20193.1K$235,000+0.20%
Q2 20193.8K$276,000+0.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Westhampton Capital, LLC’s full portfolio or all institutional holders of ABBV.